A Phase II, Single-Center, Randomized, Double-Blind, Assessment of the Abuse Liability of Acurox (oxycodone HCl and niacin) Tablets in Subjects with a History of Opioid Abuse

Trial Profile

A Phase II, Single-Center, Randomized, Double-Blind, Assessment of the Abuse Liability of Acurox (oxycodone HCl and niacin) Tablets in Subjects with a History of Opioid Abuse

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Oct 2008

At a glance

  • Drugs Niacin; Oxycodone; Oxycodone/niacin
  • Indications Drug abuse; Pain
  • Focus Pharmacodynamics; Therapeutic Use
  • Sponsors Acura Pharmaceuticals
  • Most Recent Events

    • 22 Oct 2008 Status changed from planning to completed, as reported by clinicaltrials.gov.
    • 13 Oct 2008 Top-line results have been reported by Acura Pharmaceuticals in a media release.
    • 05 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top